{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:11:23Z","timestamp":1784193083040,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.diagmicrobio.2006.06.011","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T17:49:01Z","timestamp":1156528141000},"page":"109-116","source":"Crossref","is-referenced-by-count":24,"title":["Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998\u20132004)"],"prefix":"10.1016","volume":"57","author":[{"given":"Ronald N.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Pottumarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/jac\/49.3.445","article-title":"Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime","volume":"49","author":"Ambrose","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3201\/eid1003.030252","article-title":"Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes","volume":"10","author":"Albrich","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00006454-200103000-00034","article-title":"Empiric use of cefepime in the treatment of serious urinary tract infections in children","volume":"20","author":"Arrieta","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00003495-199447030-00007","article-title":"Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use","volume":"47","author":"Barradell","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00006454-200103000-00032","article-title":"Review of pharmacokinetics of cefepime in children","volume":"20","author":"Blumer","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00006454-200103000-00030","article-title":"Introduction. The safety and efficacy of cefepime in pediatrics","volume":"20","author":"Bradley","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib7","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1128\/AAC.49.7.2760-2766.2005","article-title":"Population pharmacokinetics of cefepime in the neonate","volume":"49","author":"Capparelli","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib8","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib9","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006454-200203000-00009","article-title":"Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer","volume":"21","author":"Chuang","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/08880010590896297","article-title":"Cefepime versus ceftazidime plus amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost","volume":"22","author":"Corapcioglu","year":"2005","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib12","series-title":"Prescribing information for Maxipime\u00ae","author":"Elan Pharmaceuticals","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/32.suppl_B.87","article-title":"Cefepime: overview of activity in vitro and in vivo","volume":"32","author":"Grassi","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4065\/75.1.86","article-title":"Antimicrobial therapy for infants and children: guidelines for the inpatient and outpatient practice of pediatric infectious diseases","volume":"75","author":"Henry","year":"2000","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib15","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/00006454-200308001-00002","article-title":"Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children","volume":"22","author":"Jacobs","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0732-8893(03)00015-4","article-title":"Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000\u20132001): report from SENTRY Antimicrobial Surveillance Program","volume":"46","author":"Jones","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10096-004-1133-5","article-title":"Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine and skin and soft tissue infections in pediatric patients","volume":"23","author":"Jones","year":"2004","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib19","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1128\/AAC.47.6.1790-1797.2003","article-title":"Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis clinical isolates from children: results from 2000\u20132001 and 2001\u20132002 TRUST studies in the United States","author":"Karlowsky","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/mpo.1107","article-title":"Randomised comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors","volume":"36","author":"Kebudi","year":"2001","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00006454-200103000-00031","article-title":"Cefepime microbiologic profile and update","volume":"20","author":"Kessler","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/pbc.10442","article-title":"Cefepime versus meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours","volume":"42","author":"Kutluk","year":"2004","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.pcl.2005.02.008","article-title":"Guidelines for the selection of antibacterial therapy in children","volume":"52","author":"Pong","year":"2005","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006454-200103000-00035","article-title":"Cefepime in the empiric treatment of meningitis in children","volume":"20","author":"Saez-Llorens","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.diagmicrobio.2006.06.011_bib25","doi-asserted-by":"crossref","first-page":"216S","DOI":"10.1592\/phco.24.18.216S.52237","article-title":"Treating serious infections: focus on cefepime","volume":"24","author":"Wong-Beringer","year":"2004","journal-title":"Pharmacotherapy"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306002355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306002355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T01:22:41Z","timestamp":1547428961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889306002355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0732889306002355"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2006.06.011","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}